{
    "clinical_study": {
        "@rank": "112709", 
        "arm_group": {
            "arm_group_label": "Patients with Rheumatoid Arthritis"
        }, 
        "brief_summary": {
            "textblock": "This non-interventional, descriptive, cross-sectional and multicenter study will examine the\n      treatment of rheumatoid arthritis progressing for less than two years in the Algerian\n      population. Current drug therapy as well as disease status and patient function will be\n      assessed."
        }, 
        "brief_title": "Study of the Treatment of Algerian Patients With Early Rheumatoid Arthritis", 
        "completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "condition": "Rheumatoid Arthritis", 
        "condition_browse": {
            "mesh_term": [
                "Arthritis", 
                "Arthritis, Rheumatoid"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Rheumatoid arthritis progressing for < 2 years.\n\n        Exclusion Criteria:\n\n          -  Rheumatoid arthritis progressing for < 3 months.\n\n          -  Rheumatoid arthritis onset at < 18 years of age.\n\n          -  Participation in another clinical study.\n\n          -  Rheumatoid arthritis related connective tissue disorder.\n\n          -  Any neuropsychological disorders."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with Rheumatoid Arthritis that has been progressing for > 3 months and < 2 years."
            }
        }, 
        "enrollment": {
            "#text": "532", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02008266", 
            "org_study_id": "ML25384"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 6, 2013", 
        "number_of_groups": "1", 
        "official_title": "Case Study of the Treatment of Early Rheumatoid Arthritis in Algerian Patients in Both the Private and Public Healthcare Sectors.", 
        "overall_official": {
            "affiliation": "Hoffmann-La Roche", 
            "last_name": "Clinical Trials", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Algeria: Minist\u00e8re de la Sant\u00e9 de la Population et de la R\u00e9forme Hospitali\u00e8re"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Describe medications used in the treatment of rheumatoid arthritis with < 2 years' progression.", 
            "safety_issue": "No", 
            "time_frame": "Single observational visit [Day 1]"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02008266"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Measure disease activity using DAS 28 assessment.", 
                "safety_issue": "No", 
                "time_frame": "Single observational visit [Day 1]"
            }, 
            {
                "measure": "Assess joint damage using the modified SHARP method.", 
                "safety_issue": "No", 
                "time_frame": "Single observational visit [Day 1]"
            }, 
            {
                "measure": "Assess functional status of patients using the Health Assessment Questionnaire (HAQ).", 
                "safety_issue": "No", 
                "time_frame": "Single observational visit [Day 1]"
            }
        ], 
        "source": "Hoffmann-La Roche", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hoffmann-La Roche", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2011", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "December 2013"
    }
}